Search alternatives:
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
50 c » 50 _ (Expand Search), 50 μ (Expand Search), 5 c (Expand Search)
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
50 c » 50 _ (Expand Search), 50 μ (Expand Search), 5 c (Expand Search)
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
Mesothelin expression and RG7787 uptake is decreased in KLM-1-R.
Published 2015“…<p><b>A</b>: Surface mesothelin levels are 5-fold lower in resistant KLM-1 (KLM-1-R) compared to KLM-1. …”
-
150
-
151
-
152
-
153
-
154
-
155
Annual treatment frequencies in recurrence and non-recurrence groups.
Published 2025“…(<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g007" target="_blank">Fig 7</a>). Mean outpatient visits in the recurrence group decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, p < 0.001). …”
-
156
Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines.
Published 2013“…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC<sub>50</sub> concentration of fenretinide during different time points (24–48–72 hours). …”
-
157
-
158
-
159
-
160